Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John T Reilly

Showing results (11-20 of 72) with videos related to

Pageof 8
Sort By:
European Journal of Haematology. Supplementum|August 31, 2007
Implications of the consensus definition of clinical resistance and intolerance to hydroxyurea for clinical practiceJohn T Reilly
Hematology (Amsterdam, Netherlands)|January 22, 2009
Anagrelide for the treatment of essential thrombocythemia: a survey among European hematologists/oncologistsJohn T Reilly
Hematology (Amsterdam, Netherlands)|September 5, 2012
Current treatment practices for essential thrombocythemia: survey results from European hematologists/oncologistsJohn T Reilly
Leukemia & Lymphoma|May 10, 2013
Chronic neutrophilic leukemia with plasma cell dyscrasia: friends or relatives?Wendy N Erber, John T Reilly
European Journal of Haematology. Supplementum|August 31, 2007
Myeloproliferative disorders: a time of new definitions. Outflow from New Horizons in Haematology Meeting, 9-10 March 2007Radek Skoda, Tiziano Barbui, John T Reilly
British Journal of Haematology|July 25, 2003
Neutrophil inclusions in cryoglobulinaemiaStuart T Laidlaw, Bart Wagner, John T Reilly
British Journal of Haematology|March 29, 2002
Cyclophosphamide-induced nail pigmentationMuralikrishnan Srikant, Joost Van Veen, Ajay Raithatha, et al.
Best Practice & Research. Clinical Haematology|June 20, 2006
Myelofibrosis with myeloid metaplasia: disease overview and non-transplant treatment optionsRuben A Mesa, Giovanni Barosi, Francisco Cervantes, et al.
British Journal of Haematology|August 26, 2004
Absence of mutations in the key megakaryocyte transcriptional regulator FOG-1 in patients with idiopathic myelofibrosisChris Fisher, David Steensma, Riaz Janmohamed, et al.
Cytometry. Part B, Clinical Cytometry|June 22, 2013
Comparison of methodological data measurement limits in CD4⁺ T lymphocyte flow cytometric enumeration and their clinical impact on HIV managementLiam Whitby, Alison Whitby, Matthew Fletcher, et al.
Pageof 8

Showing results (11-20 of 72) with videos related to

Sort By:
Pageof 8
European Journal of Haematology. Supplementum|August 31, 2007
Implications of the consensus definition of clinical resistance and intolerance to hydroxyurea for clinical practiceJohn T Reilly
Hematology (Amsterdam, Netherlands)|January 22, 2009
Anagrelide for the treatment of essential thrombocythemia: a survey among European hematologists/oncologistsJohn T Reilly
Hematology (Amsterdam, Netherlands)|September 5, 2012
Current treatment practices for essential thrombocythemia: survey results from European hematologists/oncologistsJohn T Reilly
Leukemia & Lymphoma|May 10, 2013
Chronic neutrophilic leukemia with plasma cell dyscrasia: friends or relatives?Wendy N Erber, John T Reilly
European Journal of Haematology. Supplementum|August 31, 2007
Myeloproliferative disorders: a time of new definitions. Outflow from New Horizons in Haematology Meeting, 9-10 March 2007Radek Skoda, Tiziano Barbui, John T Reilly
British Journal of Haematology|July 25, 2003
Neutrophil inclusions in cryoglobulinaemiaStuart T Laidlaw, Bart Wagner, John T Reilly
British Journal of Haematology|March 29, 2002
Cyclophosphamide-induced nail pigmentationMuralikrishnan Srikant, Joost Van Veen, Ajay Raithatha, et al.
Best Practice & Research. Clinical Haematology|June 20, 2006
Myelofibrosis with myeloid metaplasia: disease overview and non-transplant treatment optionsRuben A Mesa, Giovanni Barosi, Francisco Cervantes, et al.
British Journal of Haematology|August 26, 2004
Absence of mutations in the key megakaryocyte transcriptional regulator FOG-1 in patients with idiopathic myelofibrosisChris Fisher, David Steensma, Riaz Janmohamed, et al.
Cytometry. Part B, Clinical Cytometry|June 22, 2013
Comparison of methodological data measurement limits in CD4⁺ T lymphocyte flow cytometric enumeration and their clinical impact on HIV managementLiam Whitby, Alison Whitby, Matthew Fletcher, et al.
Pageof 8